Biobanking Market Size, Trends, Analysis, and Outlook By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others), by Country, Segment, and Companies, 2024-2032
The global Biobanking market size is poised to register 7.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biobanking market across By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others)
The biobanking market is driven by the growing demand for high-quality biospecimens, advancements in biorepository management, and the need for standardized and interoperable data systems. By 2030, the market is expected to witness robust growth, fueled by innovations in sample collection, processing, and storage technologies. Further, expanding applications in precision medicine, genomics research, and drug development are anticipated to drive market expansion, enabling biobanks to support translational research, biomarker discovery, and personalized healthcare initiatives with diverse and well-characterized biological samples.
Biobanking Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biobanking market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biobanking survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biobanking industry.
Key market trends defining the global Biobanking demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biobanking Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Biobanking industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biobanking companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biobanking industry
Leading Biobanking companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biobanking companies.
Biobanking Market Study- Strategic Analysis Review
The Biobanking market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Biobanking industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Biobanking Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Biobanking Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Biobanking market segments. Similarly, Strong market demand is encouraging Canadian Biobanking companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Biobanking market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biobanking Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biobanking industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Biobanking market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biobanking Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biobanking in Asia Pacific. In particular, China, India, and South East Asian Biobanking markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Biobanking Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biobanking Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biobanking market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biobanking.
Biobanking Market Company Profiles
The global Biobanking market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AMS Biotechnology Ltd, ASKION GmbH, Avantor Inc, Azenta Inc, Bay Biosciences LLC, Becton, Dickinson and Company, BioKryo GmbH, Cell&Co BioServices SAS, Cryoport Inc, CTIBiotech, Cureline Inc, Firalis Group, Greiner Holding AG, Hamilton Company, Merck KGaA, Micronic Europe B.V., PHC Holdings Corp, ProteoGenex Inc, QIAGEN N.V., Sopachem NV, SPT Labtech Ltd, Tecan Trading AG, Thermo Fisher Scientific Inc, US Biolab Corp Inc, Ziath Ltd.
Recent Biobanking Market Developments
The global Biobanking market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biobanking Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
Geographical Segmentation:
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd
Formats Available: Excel, PDF, and PPT
The biobanking market is driven by the growing demand for high-quality biospecimens, advancements in biorepository management, and the need for standardized and interoperable data systems. By 2030, the market is expected to witness robust growth, fueled by innovations in sample collection, processing, and storage technologies. Further, expanding applications in precision medicine, genomics research, and drug development are anticipated to drive market expansion, enabling biobanks to support translational research, biomarker discovery, and personalized healthcare initiatives with diverse and well-characterized biological samples.
Biobanking Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biobanking market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biobanking survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biobanking industry.
Key market trends defining the global Biobanking demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biobanking Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Biobanking industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biobanking companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biobanking industry
Leading Biobanking companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biobanking companies.
Biobanking Market Study- Strategic Analysis Review
The Biobanking market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Biobanking industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Biobanking Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Biobanking Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Biobanking market segments. Similarly, Strong market demand is encouraging Canadian Biobanking companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Biobanking market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biobanking Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biobanking industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Biobanking market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biobanking Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biobanking in Asia Pacific. In particular, China, India, and South East Asian Biobanking markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Biobanking Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biobanking Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biobanking market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biobanking.
Biobanking Market Company Profiles
The global Biobanking market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AMS Biotechnology Ltd, ASKION GmbH, Avantor Inc, Azenta Inc, Bay Biosciences LLC, Becton, Dickinson and Company, BioKryo GmbH, Cell&Co BioServices SAS, Cryoport Inc, CTIBiotech, Cureline Inc, Firalis Group, Greiner Holding AG, Hamilton Company, Merck KGaA, Micronic Europe B.V., PHC Holdings Corp, ProteoGenex Inc, QIAGEN N.V., Sopachem NV, SPT Labtech Ltd, Tecan Trading AG, Thermo Fisher Scientific Inc, US Biolab Corp Inc, Ziath Ltd.
Recent Biobanking Market Developments
The global Biobanking market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biobanking Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Biobanking Market Overview and Key Findings, 2024
1.2 Biobanking Market Size and Growth Outlook, 2021- 2030
1.3 Biobanking Market Growth Opportunities to 2030
1.4 Key Biobanking Market Trends and Challenges
1.4.1 Biobanking Market Drivers and Trends
1.4.2 Biobanking Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biobanking Companies
2. BIOBANKING MARKET SIZE OUTLOOK TO 2030
2.1 Biobanking Market Size Outlook, USD Million, 2021- 2030
2.2 Biobanking Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOBANKING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOBANKING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biobanking Market, 2025
5.2 Asia Pacific Biobanking Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biobanking Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biobanking Market, 2025
5.5 Europe Biobanking Market Size Outlook by Type, 2021- 2030
5.6 Europe Biobanking Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biobanking Market, 2025
5.8 North America Biobanking Market Size Outlook by Type, 2021- 2030
5.9 North America Biobanking Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biobanking Market, 2025
5.11 South America Pacific Biobanking Market Size Outlook by Type, 2021- 2030
5.12 South America Biobanking Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biobanking Market, 2025
5.14 Middle East Africa Biobanking Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biobanking Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biobanking Market Size Outlook and Revenue Growth Forecasts
6.2 US Biobanking Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biobanking Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biobanking Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biobanking Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biobanking Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biobanking Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biobanking Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biobanking Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biobanking Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biobanking Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biobanking Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biobanking Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biobanking Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biobanking Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biobanking Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biobanking Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biobanking Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biobanking Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biobanking Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biobanking Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biobanking Industry Drivers and Opportunities
7. BIOBANKING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOBANKING COMPANY PROFILES
8.1 Profiles of Leading Biobanking Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Biobanking Market Overview and Key Findings, 2024
1.2 Biobanking Market Size and Growth Outlook, 2021- 2030
1.3 Biobanking Market Growth Opportunities to 2030
1.4 Key Biobanking Market Trends and Challenges
1.4.1 Biobanking Market Drivers and Trends
1.4.2 Biobanking Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biobanking Companies
2. BIOBANKING MARKET SIZE OUTLOOK TO 2030
2.1 Biobanking Market Size Outlook, USD Million, 2021- 2030
2.2 Biobanking Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOBANKING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOBANKING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biobanking Market, 2025
5.2 Asia Pacific Biobanking Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biobanking Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biobanking Market, 2025
5.5 Europe Biobanking Market Size Outlook by Type, 2021- 2030
5.6 Europe Biobanking Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biobanking Market, 2025
5.8 North America Biobanking Market Size Outlook by Type, 2021- 2030
5.9 North America Biobanking Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biobanking Market, 2025
5.11 South America Pacific Biobanking Market Size Outlook by Type, 2021- 2030
5.12 South America Biobanking Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biobanking Market, 2025
5.14 Middle East Africa Biobanking Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biobanking Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biobanking Market Size Outlook and Revenue Growth Forecasts
6.2 US Biobanking Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biobanking Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biobanking Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biobanking Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biobanking Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biobanking Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biobanking Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biobanking Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biobanking Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biobanking Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biobanking Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biobanking Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biobanking Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biobanking Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biobanking Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biobanking Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biobanking Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biobanking Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biobanking Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biobanking Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biobanking Industry Drivers and Opportunities
7. BIOBANKING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOBANKING COMPANY PROFILES
8.1 Profiles of Leading Biobanking Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
